Staidson (Beijing) BioPharmaceuticals Co., Ltd. Stock: price and insider trades · China
舒泰神
Staidson (Beijing) BioPharmaceuticals Co., Ltd.: what insiders have been doing
Every trade that managers of Staidson (Beijing) BioPharmaceuticals Co., Ltd. disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Health Care sector. Staidson (Beijing) BioPharmaceuticals Co., Ltd. has had no insider filing for more than a year; the last one goes back to 21 April 2022.
The full history, which starts in 2021, counts no purchases against 2 sales.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About Staidson (Beijing) BioPharmaceuticals Co., Ltd.
舒泰神 is a company focused on the health and pharmaceutical sector, dedicated to the development of innovative drugs. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
